Propofol injectable - Phosphagenics

Drug Profile

Propofol injectable - Phosphagenics

Alternative Names: Propofol Injectable Emulsion/TPM; TPM/Propofol Injectable Emulsion; TPM®/Propofol injectable

Latest Information Update: 05 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phosphagenics
  • Class General anaesthetics; Phenols; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Anaesthesia

Most Recent Events

  • 09 Nov 2017 Phosphagenics and Terumo have a patent pending for TPM® based Propofol
  • 16 Feb 2016 Preclinical trials in Anaesthesia in Australia (Injection)
  • 17 Mar 2014 Early research in Anaesthesia in Australia (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top